<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03951714</url>
  </required_header>
  <id_info>
    <org_study_id>CLI-01535AA1-01</org_study_id>
    <nct_id>NCT03951714</nct_id>
  </id_info>
  <brief_title>Effect of the Use of an add-on Device Connected to a Smartphone App on Difficult-to-treat Asthmatic Patient's Adherence</brief_title>
  <acronym>ADVICE</acronym>
  <official_title>12-wks Randomised Controlled Trial to Explore the Effect of a Smartphone App. Connected to an Add-on Device System Fitted on pMDI Inhaler on Adherence to Medications Intake and Clinical Outcomes in Difficult-to-treat Asthmatic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chiesi Farmaceutici S.p.A.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chiesi Farmaceutici S.p.A.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this Study is to assess the effect of a smartphone application connected to an&#xD;
      add-on device system fitted on Pressured Metered Dose Inhaler (PMDI) on adherence to take&#xD;
      medications as prescribed and clinical outcomes in difficult-to-treat asthmatic patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 12, 2019</start_date>
  <completion_date type="Actual">July 6, 2020</completion_date>
  <primary_completion_date type="Actual">July 6, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Baseline in adherence rate to entire treatment period</measure>
    <time_frame>From baseline to end of participation (up to 3 months)</time_frame>
    <description>Adherence Rate of doses correctly taken twice daily</description>
  </primary_outcome>
  <other_outcome>
    <measure>Asthma Control Test score</measure>
    <time_frame>From baseline to end of participation (up to 3 months)</time_frame>
    <description>Change from Baseline</description>
  </other_outcome>
  <other_outcome>
    <measure>Test of the Adherence to Inhalers score</measure>
    <time_frame>From baseline to end of participation (up to 3 months)</time_frame>
    <description>Change from Baseline</description>
  </other_outcome>
  <other_outcome>
    <measure>Percentage of days without intake of rescue medication</measure>
    <time_frame>From baseline to end of participation (up to 3 months)</time_frame>
    <description>Change from Baseline</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">160</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>Reference</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Control experience using marketed application to record medication intake without reminders from the app</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Full experience using marketed application, with all functionalities enabled</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Marketed experience application on adherence</intervention_name>
    <description>To evaluate the effect of electronic capture of medication intake through a smartphone app on treatment's adherence</description>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_label>Reference</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient's written informed consent obtained prior to any study-related procedures&#xD;
&#xD;
          -  Male or female patient aged 18 years and above&#xD;
&#xD;
          -  Patient with established diagnosis of asthma for at least 6 months&#xD;
&#xD;
          -  Patient on maintenance therapy (Fixed dose combination ICS/LABA) with high dose of ICS&#xD;
&#xD;
          -  Patient with ACT score &lt;20 at screening and at randomization&#xD;
&#xD;
          -  Non- or ex-smoker who smoked ≤ 10 Pack-years prior to screening&#xD;
&#xD;
          -  Patient must have their own Android® or iPhone operating system (IOS) smartphone&#xD;
&#xD;
          -  Ability to use the pMDI device correctly&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient with an asthma exacerbation or respiratory tract infection requiring systemic&#xD;
             steroids and/or antibiotics within 1 to 3 month prior to screening&#xD;
&#xD;
          -  Patient with a history of near-fatal asthma&#xD;
&#xD;
          -  Clinically relevant and uncontrolled cardiac, hepatic, renal, gastrointestinal,&#xD;
             endocrine, metabolic, neurologic, psychiatric or any other disorder that would put the&#xD;
             safety of the subject at risk through participation, or which would affect the&#xD;
             analysis&#xD;
&#xD;
          -  Patient not able to be compliant with the study requirements.&#xD;
&#xD;
          -  Patient with a BMI &gt; 40&#xD;
&#xD;
          -  Patient working on night shifts&#xD;
&#xD;
          -  Patient participating in the clinical phase of an interventional trial or have done so&#xD;
             within the last 30 days prior to screening.&#xD;
&#xD;
          -  Patient who has an already planned major surgery or hospitalization&#xD;
&#xD;
          -  Female patient who is pregnant or lactating or who plans to become pregnant in the&#xD;
             next 4 months.&#xD;
&#xD;
          -  Patient with a history of hypersensitivity to any of the components of Foster pMDI&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Annaliese Linnhoff</last_name>
    <role>Principal Investigator</role>
    <affiliation>Research Center for Medical Studies Praxis für Lungen- und Bronchialheilkunde</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Barlow Medical Centre</name>
      <address>
        <city>Manchester</city>
        <zip>M20 2RN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>https://www.chiesi.com/en/chiesi-clinical-study-register/</url>
    <description>Structured Summary Data Results on Chiesi Clinical Study Register</description>
  </link>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>May 14, 2019</study_first_submitted>
  <study_first_submitted_qc>May 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 15, 2019</study_first_posted>
  <last_update_submitted>June 28, 2021</last_update_submitted>
  <last_update_submitted_qc>June 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Post-market study</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

